Business Description
Vivos Inc
NAICS : 339112
SIC : 3845
ISIN : US92858K1051
Description
Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.85 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 24.61 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -38.7 | |||||
| 3-Year EPS without NRI Growth Rate | -35.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.19 | |||||
| 9-Day RSI | 79.14 | |||||
| 14-Day RSI | 77 | |||||
| 6-1 Month Momentum % | 18.44 | |||||
| 12-1 Month Momentum % | -37.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.57 | |||||
| Quick Ratio | 6.57 | |||||
| Cash Ratio | 6.5 | |||||
| Days Sales Outstanding | 146 | |||||
| Days Payable | 1910.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.9 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -35 | |||||
| Operating Margin % | -13965 | |||||
| Net Margin % | -14475 | |||||
| FCF Margin % | -6465 | |||||
| ROE % | -191.09 | |||||
| ROA % | -177.13 | |||||
| ROIC % | -279300 | |||||
| ROC (Joel Greenblatt) % | -279300 | |||||
| ROCE % | -184.33 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -14.09 | |||||
| EV-to-EBITDA | -14.09 | |||||
| EV-to-Revenue | 1967.45 | |||||
| EV-to-FCF | -30.73 | |||||
| Earnings Yield (Greenblatt) % | -7.1 | |||||
| FCF Yield % | -2.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RDGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivos Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.02 | ||
| EPS (TTM) ($) | -0.01 | ||
| Beta | 0.37 | ||
| Volatility % | 85.56 | ||
| 14-Day RSI | 77 | ||
| 14-Day ATR ($) | 0.009367 | ||
| 20-Day SMA ($) | 0.093103 | ||
| 12-1 Month Momentum % | -37.53 | ||
| 52-Week Range ($) | 0.04119 - 0.12 | ||
| Shares Outstanding (Mil) | 389.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivos Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivos Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vivos Inc Frequently Asked Questions
What is Vivos Inc(RDGL)'s stock price today?
The current price of RDGL is $0.12. The 52 week high of RDGL is $0.12 and 52 week low is $0.04.
When is next earnings date of Vivos Inc(RDGL)?
The next earnings date of Vivos Inc(RDGL) is .
Does Vivos Inc(RDGL) pay dividends? If so, how much?
Vivos Inc(RDGL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers